Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma

Abstract

Hepatocellular carcinoma (HCC) is still one of the most common and rapidly fatal malignancies worldwide with a multi-factorial, multi-step, complex process, and poor prognosis. Early discovery and effective therapy of HCC are of utmost importance. Recent studies demonstrated that Wnt/β-catenin pathway play important roles in occurrence and development of HCC including hepatocytes malignant transformation, metastasis, chemoresistance and liver cancer stem cells. Oncogenic wingless-type MMTV integration site family member 3a (Wnt3a) signaling is a promising biomarker in diagnosis and prognosis for HCC. This review presents current data on mechanisms of hepatocarcinogenesis involving participation of the Wnt canonical pathway, and focuses on the Wnt3a expression in HCC progression and its clinical application.

Keywords

Hepatocellular carcinoma / Wnt/β-catenin pathway / signal molecules

References

[1] Finn RS,Farah W,Zaiem F,Murad MH.Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: a systematic review and meta-analysis.Hepatology2018;67:422-35

[2] Fujiwara N,Goossens N.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.J Hepatol2018;68:526-49

[3] Chen JG,Zhang YH,Yao DF,Lu JH,Chen HZ,Yang LP,Qiang FL.Cancer survival in Qidong between 1972 and 2011: a population-based analysis.Mol Clin Oncol2017;6:944-54 PMCID:PMC5451853

[4] Yang F,Cao GW.Hepatocellular carcinoma: co-evolution of hepatocytes and hepatitis B virus.Zhonghua Gan Zang Bing Za Zhi2017;25:321-4(in Chinese)

[5] Tong Hv,Velavan TP.Genetic insights on host and hepatitis B virus in liver diseases.Mutat Res Rev Mutat Res2014;762:65-75

[6] Du Y,Ding YB,Cao GW.Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects.World J Gastroenterol2016;22:6565-72 PMCID:PMC4970480

[7] Matsuura K.Host genetic variations associated with disease progression in chronic hepatitis C virus infection.Hepatol Res2018;48:127-33

[8] Chen LP,Du Y,Su T,Cao GW.Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.World J Virol2012;1:174-83 PMCID:PMC3782279

[9] Seto WK.Nonalcoholic fatty liver disease in Asia: emerging perspectives.J Gastroenterol2017;52:164-74

[10] Margini C.The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.Liver Int2016;36:317-24

[11] Han YF,Ma LY,Chang WJ,Cao GW.Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.World J Gastroenterol2011;17:4258-70 PMCID:PMC3214700

[12] Cao GW.Clinical relevance and public health significance of hepatitis B virus genomic variations.World J Gastroenterol2009;15:5761-9 PMCID:PMC2791267

[13] Pan L,Yao D.Clinical significance of abnormal Wnt signaling pathway expression in hepatitis and hepatocellular carcinoma.Zhonghua Gan Zang Bing Za Zhi2015;23:797-800(in Chinese)

[14] Rinninella E,Spinelli I,Mele MC,Gasbarrini A.Chemotherapy for hepatocellular carcinoma: current evidence and future perspectives.J Clin Transl Hepatol2017;5:235-48

[15] Zhan T,Boutros M.Wnt signaling in cancer.Oncogene2017;36:1461-73 PMCID:PMC5357762

[16] Noda T,Takemasa I,Murakami M,Kobayashi S,Takeda Y,Umeshita K,Matsubara K,Mori M.Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma..Br J Cancer2009;100:1647-58 PMCID:PMC2696759

[17] Yao DF,Chen SZ,Lu JX,Meng XY.Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase.Am J Clin Pathol1998;110:743-9

[18] Yao M,Bian YZ,Qiu LW,Sai WL,Zhang HJ.Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int2011;10:289-94

[19] Pan LH,Zheng WJ,Yang XL,Cai Y,Yao DF.Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.Tumour Biol2016;37:5561-8

[20] Pan LH,Cai Y,Yang XL,Yao DF.Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.World J Gastroenterol2016;22:3829-37 PMCID:PMC4814746

[21] Miller JR.The Wnts.Genome Biol2002;3:3001

[22] Arheden K,Strombeck B,Mitelman F.Chromosome localization of the human oncogene INT1 to 12q13 by in situ hybridization.Cytogenet Cell Genet1988;3:86-7

[23] McMahon JA.Nucleotide sequence, chromosomal localization and developmental expression of the mouse int-1-related gene.Development1989;3:643-50

[24] Katoh M,Sugimura T.Cloning, expression and chromosomal localization of Wnt-13, a novel member of the Wnt gene family.Oncogene1996;3:873-6

[25] Roelink H,Black DM,Nusse R.Molecular cloning and chromosomal localization to 17q21 of the human WNT3 gene.Genomics1993;3:790-2

[26] Roelink H.Expression of two members of the Wnt family during mouse development-restricted temporal and spatial patterns in the developing neural tube.Genes Dev1991;3:381-8

[27] Huguet EL,McMahon AP,Harris AL.Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue.Cancer Res1994;3:2615-21

[28] Geng M,Chen YJ,Bi LQ.Loss of Wnt5a and Ror2 protein in hepato- cellular carcinoma associated with poor prognosis.World J Gastroenterol2012;18:1328-38 PMCID:PMC3319959

[29] Saitoh T.Molecular cloning and characterization of human WNT5B on chromosome 12p13.3 region. Int J Oncol2001;3:347-51

[30] Kirikoshi H,Katoh M.WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly coexpressed in SW480 cells.Biochem Biophys Res Commun2001;3:798-805

[31] Ikegawa S,Okui K,Takahashi E.Isolation, characterization and chromosomal assignment of the human WNT7A gene.Cytogenet Cell Genet1996;3:149-52

[32] Kirikoshi H,Katoh M.Molecular cloning and characterization of human WNT7B.Int J Oncol2001;3:779-83

[33] Saitoh T.Molecular cloning and characterization of human WNT8A.Int J Oncol2001;3:123-27

[34] Lako M,Bullen P,Robson SC.A novel mammalian wnt gene, WNT8B, shows brain-restricted expression in early development, with sharply delimited expression boundaries in the developing fore-brain.Hum Mol Genet1998;3:813-22

[35] Bui TD,Smith K,Ruben S,Harris AL.A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas.Oncogene1997;3:1249-53

[36] Lako M,Bullen P,Robson SC.Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung. Gene1998;3:101-10

[37] Bergstein I,Bhalerao J,Copeland NG,Bowcock AM.Isolation of two novel WNT genes, WNT14 and WNT15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21.Genomics1997;3:450-8

[38] Fear MW,Spurr NK.Wnt-16a, a novel Wnt-16 isoform, which shows differential expression in adult human tissues.Biochem Biophys Res Commun2000;3:814-20

[39] Wang R,Wang P,Xiong S,Huang H,Geller DA.Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.Oncotarget2016;7:5754-68

[40] Mokkapati S,Huang L,Ruteshouser EC,Finegold MJ.β-Catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.Cancer Res2014;74:4515-25 PMCID:PMC4134699

[41] Guerrieri F,Pediconi N.Molecular mechanisms of HBV- associated hepatocarcinogenesis.Semin Liver Dis2013;33:147-56

[42] Daud M,Husnain T.Modulation of Wnt signaling pathway by hepatitis B virus.Arch Virol2017;162:2937-47

[43] Monga SP.β-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis.Gastroenterology2015;148:1294-310 PMCID:PMC4494085

[44] Park S,Kim JR.Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma.J Vet Sci2017;18:419-29 PMCID:PMC5746434

[45] Yen CJ,Tsai HW,Yen CS,Lee YP,Wang YC,Lin CH,Tsai HP,Su IJ.Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection.Hepatology2018;

[46] Gao Y,Yang G,Liu Y,Sun M,Chen F,Ye L.Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.Hepatology2017;66:1413-29

[47] Geng M,Bi LQ,Liu XH.Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis.World J Gastroenterol2015;21:10732-8 PMCID:PMC4600575

[48] Ashmawy AM,Abdel Salam ET,Kobaisi MH,Sharawy SK.Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.Arab J Gastroenterol2017;18:144-50

[49] Preziosi M,Singh S.Hepatocyte Wnts are dispensable during diethylnitrosamine and carbon tetrachloride-induced injury and hepatocellular cancer.Gene Expr2018;

[50] Han Y,Wang D.Hepatitis C virus protein interaction network analysis based on hepatocellular carcinoma.PLoS One2016;11:e0153882 PMCID:PMC4846009

[51] Rogacki K,Stępiński A.Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus.Pol J Pathol2015;66:9-21

[52] Wang W,Fuhler GM,Peppelenbosch MP.Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepato- cellular carcinoma.J Gastroenterol2017;52:419-31 PMCID:PMC5357489

[53] Jiang XH,Cai YP,Ma T.Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway.BMC Microbiol2017;17:124 PMCID:PMC5445264

[54] Liu J,Tang J,Hu P,Shan X,Chen Q,Zhang B,Chen K,Huang A,Tang N.Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.PLoS One2011;6:e27496 PMCID:PMC3216985

[55] Liu J,Tang J,Shan X,Chen Q,Chen K,Tang N.Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line.Arch Virol2011;156:1013-23

[56] Kasprzak A,Adamek A,Przybyszewska W,Helak-Łapaj C.Tissue expression of β-catenin and E- and N-cadherins in chronic hepatitis C and hepatocellular carcinoma.Arch Med Sci2017;13:1269-80 PMCID:PMC5701691

[57] Umer M,Hashmi ZY,Ahmad J,Iqbal M.Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.Virol J2014;11:117 PMCID:PMC4076499

[58] Liu Y,Jiao L,Moore D,Tavakoli-Tabasi S,Kuzniarek J,White DL.WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.PLoS One2013;8:e84407 PMCID:PMC3875538

[59] Quan H,Nie D,Cai X,Zhou Z,Huang A,Tang N.Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.Oncogene2014;33:2826-35

[60] Ueda T,Horimoto K,Saito S,Sakai Y,Takatori H,Kaneko S.Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.Genomics2013;101:238-48

[61] Lu C,Duan J,Zhong C,Liao W,Zhu R.Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis.Int J Oncol2017;51:1135-45 PMCID:PMC5592886

[62] Zhang C,Chen X,Yin B,Zhang Y.Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.Clin Transl Oncol2017;19:1507-17

[63] Sakabe T,Umekita Y,Hatano E,Shiota G.Expression of cancer stem cell-associated DKK1 mRNA serves as prognostic marker for hepatocellular carcinoma.Anticancer Res2017;37:4881-8

[64] Davaadorj M,Saito YU,Ikemoto T,Takasu C,Yoshikawa M.Loss of SFRP1 expression is associated with poor prognosis in hepatocellular carcinoma.Anticancer Res2016;36:659-64

[65] Wang L,Fang M,Dong ZZ,Zhang HJ.Expression of hepatic Wnt5a and its cliniopathological features in patients with hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int2018;17:227-32

[66] Wang L,Yao M,Fang M,Dong ZZ.Clinical values of Wnt3a as a novel biomarker in diagnosis and prognosis of hepatocellular carcinoma.Zhonghua Yi Xue Za Zhi2016;96:3554-8(in Chinese)

[67] Naboulsi W,Bracht T,Turewicz M,Voss DM,Hoffmann AC,Baba HA,Sitek B.Quantitative tissue proteomics analysis reveals versican as potential biomarker for early-stage hepatocellular carcinoma.J Proteome Res2016;15:38-47

[68] Su YH,Song W.DNA markers in molecular diagnostics for hepatocellular carcinoma.Expert Rev Mol Diagn2014;14:803-17 PMCID:PMC4480673

[69] Zheng WJ,Qian Q,Qiu LW,Wu W,Yao DF.Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.Oncotarget2017;8:52321-32

[70] Dong ZZ,Li Z,Chai YL,Sun HC,Ma KS.Advances in basic and clinical research on hepatocellular carcinoma in 2016.Zhonghua Gan Zang Bing Za Zhi2017;25:85-93(in Chinese)

[71] Yang Y,Fang M,Dong ZZ.Molecular markers for the monitoring of malignant transformation of hepatocytes and early diagnosis of liver cancer.Zhonghua Gan Zang Bing Za Zhi2017;25:325-8(in Chinese)

[72] Yao DF,Huang ZW,Tao QY,Meng X.Abnormal expressiom of hepatoma specific γ-glutamyl transferase and alteration of γ-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma.Cancer2000;88:761-9

[73] Yao M,Bian YZ,Yan XD,Qiu LW,Zhang HJ,Chen J.Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int2013;12:171-9

[74] Erdal H,Karatay E,Ş Elbeg.Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.Turk J Gastroenterol2016;27:375-81

[75] Guo Y,Zhang L,Guo R,Chen W,Chen G.Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.Hepatology2016;63:1240-55

[76] Witt-Kehati D,Alaluf MB,Shlomai A.Inhibition of pMAPK14 overcomes resistance to sorafenib in hepatoma cells with hepatitis B virus.Transl Oncol2018;11:511-7 PMCID:PMC5884218

[77] Shang S,Hu ZW.The regulation of β-catenin activity and function in cancer: therapeutic opportunities.Oncotarget2017;8:33972-89 PMCID:PMC5464927

[78] Liu J,Hsieh MH,Sun F,Kasibhatla S,Li AG,Li J,Pferdekamper A,Cheng J,Phung V,Wang Y,Flynn S,Li C,Schultz PG,McNamara P,Petruzzelli L,Seidel HM,Che J,Vanasse G.Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.Proc Natl Acad Sci U S A2013;110:20224-9 PMCID:PMC3864356

[79] Tuynman JB,Boon EM,Zwinderman AH,Richel DJ.Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer.Cancer Res2008;68:1213-20

[80] Su Y.Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells.Carcinogenesis2009;30:331-9

[81] Sebio A,Lenz HJ.The potential of targeting Wnt/beta-catenin in colon cancer.Expert Opin Ther Targets2014;18:611-5

[82] Takada K,Bird GH,Zhao JJ,Lemieux M,Ryan J,Fulciniti M,Xu W,Shivdasani RA,Carrasco DR.Targeted disruption of the BCL9/beta-catenin complex inhibits oncogenic Wnt signaling.Sci Transl Med2012;4:148ra117

[83] Yu D,Yao M,Yan M,Qiu L,Sai W.Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA.Tumour Biol2013;34:661-8 PMCID:PMC3597277

[84] Jin Y,Han J,Sun Z.MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.Exp Cell Res2017;360:210-7

[85] Kim SS,Lee HY,Noh CK,Lee KM,Lee KJ,Cheong JY.Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.Clin Biochem2016;49:792-801

[86] Lin HH,Lu LC,Hsu CH.Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.Cancer Lett2016;381:58-66

[87] Shen YN,Shi Y,Yuan JY,Shi CF,Wei YP,Huang JL,Lu JH.Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.Mol Carcinog2017;56:751-60

[88] Shibata T,Totoki Y.Molecular genomic landscapes of hepatobiliary cancer.Cancer Sci2018;109:1282-91 PMCID:PMC5980207